Sublingual versus subcutaneous allergen immunotherapy in bronchial asthma: A randomized controlled trial

Sublingual versus subcutaneous allergen immunotherapy in bronchial asthma: A randomized controlled trial

Background Asthma affects 300 million individuals worldwide. It is a serious global health problem affecting all age groups. The significance of eosinophilic inflammation in asthma is well established. Allergen immunotherapy (AIT) acts by increasing tolerance to specific antigens to which individual...

Full description

Bibliographic Details
Main Authors: Mohamed A Elmoniem, Magda Abdelsalam, Aida M Yousef, Marwa O Elmaria
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
immunoglobulin e
immunotherapy
sputum eosinophil
subcutaneous
sublingual
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2024;volume=73;issue=1;spage=13;epage=18;aulast=Elmoniem

Internet

http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2024;volume=73;issue=1;spage=13;epage=18;aulast=Elmoniem

Similar Items